Stem Cell Research (Apr 2021)

Establishment of a novel human iPSC line (SDQLCHi032-A) derived from a patient with primary hypertrophic osteoarthropathy caused by HPGD homozygous mutation

  • Yue Li,
  • Rui Dong,
  • Guangyu Wang,
  • Haiyan Zhang,
  • Xiaomeng Yang,
  • Zilong Li,
  • Jingyun Guan,
  • Zhongtao Gai,
  • Yi Liu

DOI
https://doi.org/10.1016/j.scr.2021.102217
Journal volume & issue
Vol. 52
p. 102217

Abstract

Read online

Primary hypertrophic osteoarthropathy, autosomal recessive type 1 (PHOAR1, MIM259100) is caused by mutations in the 15-hydroxyprostaglandin dehydrogenase gene (HPGD, MIM601688) on chromosome 4q34. An induced pluripotent stem cells (iPSCs) line was generated in our lab from peripheral blood mononuclear cells (PBMCs) of a 2-year-7-month-old girl with PHOAR1 carrying a homozygous mutation of c.310_311del in HPGD. The expression of pluripotency markers, absence of episomal vectors, preservation of normal karyotype, the potential of trilineage differentiation in vitro, were confirmed in the obtained iPSCs line.